Cargando…

An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts

ABSTRACT: Current available therapies control Myasthenia gravis (MG) reasonably well, but Health Related Quality of life (HRQOL) remains lower than expected. The aim was provide insights in how HRQOL in MG stands across borders and time, compare the scores to general population controls and other ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boldingh, M. I., Dekker, L., Maniaol, A. H., Brunborg, C., Lipka, A. F., Niks, E. H., Verschuuren, J. J. G. M., Tallaksen, C. M. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522107/ https://www.ncbi.nlm.nih.gov/pubmed/26232146 http://dx.doi.org/10.1186/s12955-015-0298-1

Ejemplares similares

Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population
por: Maniaol, Angelina H., et al.
Publicado: (2012)

Sensitivity of MG‐ADL for generalized weakness in myasthenia gravis
por: de Meel, R. H. P., et al.
Publicado: (2018)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Long‐term follow‐up, quality of life, and survival of patients with Lambert‐Eaton myasthenic syndrome
por: Lipka, Alexander F., et al.
Publicado: (2020)

Fracture rate in patients with myasthenia gravis: the general practice research database
por: Pouwels, S., et al.
Publicado: (2012)

Treating muscle-specific kinase myasthenia gravis from the inside out
por: Huijbers, Maartje G., et al.
Publicado: (2019)

Coexistence of myasthenia gravis and pemphigus foliaceus.
por: Kim, H. T., et al.
Publicado: (1995)

Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders
por: Keene, Kevin R., et al.
Publicado: (2023)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness
por: de Meel, Robert H.P., et al.
Publicado: (2020)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects
por: Popperud, Trine H., et al.
Publicado: (2021)

MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity
por: Huijbers, Maartje G., et al.
Publicado: (2019)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials
por: Vrinten, Charlotte, et al.
Publicado: (2015)

VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
por: Avidan, Nili, et al.
Publicado: (2014)

The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy
por: Keene, Kevin R., et al.
Publicado: (2020)

Determinants of Quality of Life in Myasthenia Gravis Patients
por: Szczudlik, Piotr, et al.
Publicado: (2020)

Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning
por: Ruiter, Annabel M., et al.
Publicado: (2023)

Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis
por: Weinreich, Stephanie S., et al.
Publicado: (2017)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

A Case of Myasthenia Gravis
por: Hatangdi, M.
Publicado: (1949)

Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature
por: de Meel, Robert H.P., et al.
Publicado: (2019)

Myasthenia Gravis: Do the Subtypes Matter?
por: Murthy, J. M. K.
Publicado: (2020)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

On Two Cases of Myasthenia Gravis
por: Clarke, J. Michell
Publicado: (1905)

P-1 Prognostic factors and course of myasthenia gravis
por: Albertini, E., et al.
Publicado: (2011)

International consensus guidance for management of myasthenia gravis: Executive summary
por: Sanders, Donald B., et al.
Publicado: (2016)

Clinical delineation of myasthenia gravis in the Kingdom of Bahrain
por: Binfalah, Mohamed F., et al.
Publicado: (2022)

Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life
por: Boscoe, Audra N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_np8u1ub9vlqm6ku7m7uoou5spk